NTRP vs. HPCO, BON, MCOM, SBET, CLEU, TRNR, GXAI, SGBX, IDW, and NVFY
Should you be buying Neurotrope stock or one of its competitors? The main competitors of Neurotrope include Hempacco (HPCO), Bon Natural Life (BON), Micromobility.com (MCOM), SharpLink Gaming (SBET), China Liberal Education (CLEU), Interactive Strength (TRNR), Gaxos.ai (GXAI), Safe & Green (SGBX), IDW Media (IDW), and Nova LifeStyle (NVFY). These companies are all part of the "consumer discretionary" sector.
Hempacco (NASDAQ:HPCO) and Neurotrope (NASDAQ:NTRP) are both small-cap consumer discretionary companies, but which is the better stock? We will compare the two businesses based on the strength of their community ranking, profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.
Hempacco has higher revenue and earnings than Neurotrope. Hempacco is trading at a lower price-to-earnings ratio than Neurotrope, indicating that it is currently the more affordable of the two stocks.
Neurotrope received 180 more outperform votes than Hempacco when rated by MarketBeat users.
7.6% of Hempacco shares are owned by institutional investors. Comparatively, 3.8% of Neurotrope shares are owned by institutional investors. 53.7% of Hempacco shares are owned by insiders. Comparatively, 13.0% of Neurotrope shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Hempacco had 1 more articles in the media than Neurotrope. MarketBeat recorded 3 mentions for Hempacco and 2 mentions for Neurotrope. Neurotrope's average media sentiment score of 1.58 beat Hempacco's score of 0.00 indicating that Hempacco is being referred to more favorably in the media.
Hempacco has a net margin of -439.42% compared to Hempacco's net margin of -1,123.90%. Neurotrope's return on equity of -113.86% beat Hempacco's return on equity.
Hempacco has a beta of 1.59, meaning that its share price is 59% more volatile than the S&P 500. Comparatively, Neurotrope has a beta of 1.67, meaning that its share price is 67% more volatile than the S&P 500.
Summary
Hempacco beats Neurotrope on 10 of the 14 factors compared between the two stocks.
Get Neurotrope News Delivered to You Automatically
Sign up to receive the latest news and ratings for NTRP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NTRP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Neurotrope Competitors List
Related Companies and Tools
